TissueTech Fleshes Out $10 Million Equity Round

TissueTech says it's raised $10 million in equity financing for its regenerative medicine technology. TissueTech Inc. said it pulled down $10 million from a pair of venture capital shops to back its regenerative medicine subsidiaries, Bio-Tissue and Amniox Medical. The equity round came from Ballast Point Ventures and River Cities Capital Funds, according to a press release.

Help employers find you! Check out all the jobs and post your resume.